Are there clinical studies showing Lyrica (pregabalin) improves or harms athletic performance?
Public clinical research on pregabalin (Lyrica) is mostly focused on conditions like neuropathic pain, fibromyalgia, and epilepsy—not on athletic performance outcomes such as endurance, strength, sprint time, or reaction time [1]. As a result, there is no clear body of evidence showing pregabalin reliably improves athletic performance.
What effects would studies suggest pregabalin has that could matter for training and competition?
Even without “athlete performance” trials, pregabalin’s known pharmacology and side-effect profile suggest plausible ways it could affect performance: it commonly causes dizziness, sleepiness, and impaired coordination in some people [2]. If those effects occur, they can reduce training capacity or on-field skills that rely on alertness, balance, and reaction time.
Does pregabalin affect sports safety, coordination, or reaction time?
Studies in broader populations (not athletes) and post-marketing experience report central nervous system side effects that matter for sports safety—especially driving-type impairments such as drowsiness and dizziness [2]. For athletes, that translates to potential risk around activities requiring fine motor control and steady coordination, particularly after starting pregabalin or increasing the dose.
How do athletes typically handle pregabalin if they’re in drug-testing programs?
If your question is partly motivated by eligibility rules, it depends on the sport and anti-doping organization. Pregabalin can be subject to restrictions depending on the governing body and whether it’s allowed with documentation (for example, therapeutic use exemptions). The safest route is to check your specific organization’s current prohibited/monitored list and rules for documentation.
What’s the best way to find athlete-relevant data for pregabalin?
If you want to search for the most athlete-relevant evidence, look for terms tied to performance endpoints rather than just “pregabalin”:
- “pregabalin” + “reaction time”
- “pregabalin” + “psychomotor”
- “pregabalin” + “driving simulator”
- “pregabalin” + “balance” or “gait”
Those types of studies are more likely to map onto practical performance and safety than trials focused on pain or seizure control [2].
Practical takeaway for performance expectations
There are no widely recognized studies directly demonstrating that Lyrica improves athletic performance, while its common side effects (like drowsiness/dizziness) could plausibly worsen aspects of performance in some users [2]. If you’re considering pregabalin use while training or competing, it’s important to treat side effects—especially early in treatment or after dose changes—as the main performance variable rather than expecting a performance benefit.
Sources:
[1] https://clinicaltrials.gov/ (Search results for “pregabalin” emphasize pain/neuropathy, epilepsy, and similar indications rather than athletic-performance outcomes)
[2] https://www.accessdata.fda.gov/ (FDA prescribing information for pregabalin/Lyrica, including warnings about dizziness and somnolence)